{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:22:39Z","timestamp":1793917359716,"version":"4.8.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/NO13840\/1"],"award-info":[{"award-number":["MR\/NO13840\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/M008797\/1"],"award-info":[{"award-number":["MR\/M008797\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"RCUK | Medical Research Council","doi-asserted-by":"publisher","award":["MR\/NO13840\/1"],"award-info":[{"award-number":["MR\/NO13840\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Medical Research Council SHIELD antimicrobial resistance consortium, NIHR Research Professorship"},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT107931\/Z\/15\/Z"],"award-info":[{"award-number":["WT107931\/Z\/15\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["207556\/Z\/17\/Z"],"award-info":[{"award-number":["207556\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["215542\/Z\/19\/Z"],"award-info":[{"award-number":["215542\/Z\/19\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["214539\/Z\/18\/Z"],"award-info":[{"award-number":["214539\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["211153\/Z\/18\/Z"],"award-info":[{"award-number":["211153\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Lister Institute for Preventive Medicine, Newcastle NIHR Biomedical Research Centre (BRC), Barbour Foundation, UK-Coronavirus Immunology Consortium","id":[{"id":"https:\/\/ror.org\/03356n642","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Barbour Foundation UK-Coronavirus Immunology Consortium"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The nasal epithelium is a plausible entry point for SARS-CoV-2, a site of pathogenesis and transmission, and may initiate the host response to SARS-CoV-2. Antiviral interferon (IFN) responses are critical to outcome of SARS-CoV-2. Yet little is known about the interaction between SARS-CoV-2 and innate immunity in this tissue. Here we apply single-cell RNA sequencing and proteomics to a primary cell model of human nasal epithelium differentiated at air-liquid interface. SARS-CoV-2 demonstrates widespread tropism for nasal epithelial cell types. The host response is dominated by type I and III IFNs and interferon-stimulated gene products. This response is notably delayed in onset relative to viral gene expression and compared to other respiratory viruses. Nevertheless, once established, the paracrine IFN response begins to impact on SARS-CoV-2 replication. When provided prior to infection, recombinant IFN\u03b2 or IFN\u03bb1 induces an efficient antiviral state that potently restricts SARS-CoV-2 viral replication, preserving epithelial barrier integrity. These data imply that the IFN-I\/III response to SARS-CoV-2 initiates in the nasal airway and suggest nasal delivery of recombinant IFNs to be a potential chemoprophylactic strategy.<\/jats:p>","DOI":"10.1038\/s41467-021-27318-0","type":"journal-article","created":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T06:02:38Z","timestamp":1638856958000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":127,"title":["Delayed induction of type I and III interferons mediates nasal epithelial cell permissiveness to SARS-CoV-2"],"prefix":"10.1038","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4138-5309","authenticated-orcid":false,"given":"Catherine F.","family":"Hatton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9595-4605","authenticated-orcid":false,"given":"Rachel A.","family":"Botting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3411-4068","authenticated-orcid":false,"given":"Maria Emilia","family":"Due\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5795-0440","authenticated-orcid":false,"given":"Iram J.","family":"Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5804-9419","authenticated-orcid":false,"given":"Bernard","family":"Verdon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3360-587X","authenticated-orcid":false,"given":"Benjamin J.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0710-9266","authenticated-orcid":false,"given":"Jarmila Stremenova","family":"Spegarova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0421-6610","authenticated-orcid":false,"given":"Florian","family":"Gothe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8729-9823","authenticated-orcid":false,"given":"Aaron I.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1130-9295","authenticated-orcid":false,"given":"Sandra","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4767-020X","authenticated-orcid":false,"given":"James P.","family":"Garnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Carrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1199-8406","authenticated-orcid":false,"given":"Jason","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4381-8729","authenticated-orcid":false,"given":"C. M. Anjam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1996-944X","authenticated-orcid":false,"given":"Lei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafiqul","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6128-9560","authenticated-orcid":false,"given":"Jonathan","family":"Coxhead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracey","family":"Davey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4731-7294","authenticated-orcid":false,"given":"A. John","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3927-2084","authenticated-orcid":false,"given":"Muzlifah","family":"Haniffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7954-3267","authenticated-orcid":false,"given":"Sophie","family":"Hambleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4591-8299","authenticated-orcid":false,"given":"Malcolm","family":"Brodlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6954-9611","authenticated-orcid":false,"given":"Chris","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Trost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4181-2315","authenticated-orcid":false,"given":"Christopher J. A.","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,12,7]]},"reference":[{"key":"27318_CR1","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. A novel coronavirus from patients with pneumonia in China, 2019. N. Engl. J. Med. 382, 727\u2013733 (2020).","journal-title":"N. Engl. J. Med"},{"key":"27318_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann, M. et al. SARS-CoV-2 Cell entry depends on ACE2 and TMPRSS2 and Is blocked by a clinically proven Protease inhibitor. Cell 181, 271\u2013280 e278 (2020).","journal-title":"Cell"},{"key":"27318_CR3","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang, C. et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395, 497\u2013506 (2020).","journal-title":"Lancet"},{"key":"27318_CR4","doi-asserted-by":"publisher","first-page":"m3339","DOI":"10.1136\/bmj.m3339","volume":"370","author":"SR Knight","year":"2020","unstructured":"Knight, S. R. et al. Risk stratification of patients admitted to hospital with covid-19 using the ISARIC WHO clinical characterisation protocol: development and validation of the 4C mortality score. BMJ 370, m3339 (2020).","journal-title":"BMJ"},{"key":"27318_CR5","doi-asserted-by":"publisher","unstructured":"Group, R. C. et al. Dexamethasone in hospitalized patients with Covid-19\u2014preliminary report. N. Engl. J. Med. https:\/\/doi.org\/10.1056\/NEJMoa2021436 (2020).","DOI":"10.1056\/NEJMoa2021436"},{"key":"27318_CR6","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","volume":"397","author":"RC Group","year":"2021","unstructured":"Group, R. C. Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet 397, 1637\u20131645 (2021).","journal-title":"Lancet"},{"key":"27318_CR7","doi-asserted-by":"publisher","first-page":"m3862","DOI":"10.1136\/bmj.m3862","volume":"371","author":"M Cevik","year":"2020","unstructured":"Cevik, M., Kuppalli, K., Kindrachuk, J. & Peiris, M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ 371, m3862 (2020).","journal-title":"BMJ"},{"key":"27318_CR8","doi-asserted-by":"publisher","unstructured":"Chen, M. et al. Elevated ACE-2 expression in the olfactory neuroepithelium: implications for anosmia and upper respiratory SARS-CoV-2 entry and replication. Eur. Respir. J. 56, https:\/\/doi.org\/10.1183\/13993003.01948-2020 (2020).","DOI":"10.1183\/13993003.01948-2020"},{"key":"27318_CR9","doi-asserted-by":"publisher","unstructured":"Hoagland, D. A. et al. Leveraging the antiviral type I interferon system as a first line of defense against SARS-CoV-2 pathogenicity. Immunity, https:\/\/doi.org\/10.1016\/j.immuni.2021.01.017 (2021).","DOI":"10.1016\/j.immuni.2021.01.017"},{"key":"27318_CR10","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41591-020-0868-6","volume":"26","author":"W Sungnak","year":"2020","unstructured":"Sungnak, W. et al. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nat. Med. 26, 681\u2013687 (2020).","journal-title":"Nat. Med."},{"key":"27318_CR11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","volume":"181","author":"CGK Ziegler","year":"2020","unstructured":"Ziegler, C. G. K. et al. SARS-CoV-2 Receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues. Cell 181, 1016\u20131035 e1019 (2020).","journal-title":"Cell"},{"key":"27318_CR12","doi-asserted-by":"publisher","first-page":"e1009130","DOI":"10.1371\/journal.ppat.1009130","volume":"16","author":"AM Gamage","year":"2020","unstructured":"Gamage, A. M. et al. Infection of human nasal epithelial cells with SARS-CoV-2 and a 382-nt deletion isolate lacking ORF8 reveals similar viral kinetics and host transcriptional profiles. PLoS Pathog. 16, e1009130 (2020).","journal-title":"PLoS Pathog."},{"key":"27318_CR13","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.cell.2020.05.042","volume":"182","author":"YJ Hou","year":"2020","unstructured":"Hou, Y. J. et al. SARS-CoV-2 reverse genetics reveals a variable infection gradient in the respiratory tract. Cell 182, 429\u2013446 e414 (2020).","journal-title":"Cell"},{"key":"27318_CR14","doi-asserted-by":"publisher","first-page":"100059","DOI":"10.1016\/j.xcrm.2020.100059","volume":"1","author":"A Pizzorno","year":"2020","unstructured":"Pizzorno, A. et al. Characterization and treatment of SARS-CoV-2 in nasal and bronchial human airway epithelia. Cell Rep. Med 1, 100059 (2020).","journal-title":"Cell Rep. Med"},{"key":"27318_CR15","doi-asserted-by":"publisher","unstructured":"Ziegler, C. G. K. et al. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Cell, https:\/\/doi.org\/10.1016\/j.cell.2021.07.023 (2021).","DOI":"10.1016\/j.cell.2021.07.023"},{"key":"27318_CR16","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1038\/s41588-020-00731-9","volume":"52","author":"OO Onabajo","year":"2020","unstructured":"Onabajo, O. O. et al. Interferons and viruses induce a novel truncated ACE2 isoform and not the full-length SARS-CoV-2 receptor. Nat. Genet. 52, 1283\u20131293 (2020).","journal-title":"Nat. Genet"},{"key":"27318_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.tig.2020.08.017","volume":"37","author":"CJA Duncan","year":"2021","unstructured":"Duncan, C. J. A., Randall, R. E. & Hambleton, S. Genetic lesions of type I interferon signalling in human antiviral immunity. Trends Genet 37, 46\u201358 (2021).","journal-title":"Trends Genet"},{"key":"27318_CR18","doi-asserted-by":"publisher","unstructured":"Zhang, Q. et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 370, https:\/\/doi.org\/10.1126\/science.abd4570 (2020).","DOI":"10.1126\/science.abd4570"},{"key":"27318_CR19","doi-asserted-by":"publisher","unstructured":"Pairo-Castineira, E. et al. Genetic mechanisms of critical illness in Covid-19. Nature, https:\/\/doi.org\/10.1038\/s41586-020-03065-y (2020).","DOI":"10.1038\/s41586-020-03065-y"},{"key":"27318_CR20","doi-asserted-by":"publisher","unstructured":"Bastard, P. et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 370, https:\/\/doi.org\/10.1126\/science.abd4585 (2020).","DOI":"10.1126\/science.abd4585"},{"key":"27318_CR21","doi-asserted-by":"publisher","unstructured":"Lokugamage, K. G. et al. Type I interferon susceptibility distinguishes SARS-CoV-2 from SARS-CoV. J Virol 94, https:\/\/doi.org\/10.1128\/JVI.01410-20 (2020).","DOI":"10.1128\/JVI.01410-20"},{"key":"27318_CR22","doi-asserted-by":"publisher","first-page":"13958","DOI":"10.1074\/jbc.AC120.013788","volume":"295","author":"U Felgenhauer","year":"2020","unstructured":"Felgenhauer, U. et al. Inhibition of SARS-CoV-2 by type I and type III interferons. J. Biol. Chem. 295, 13958\u201313964 (2020).","journal-title":"J. Biol. Chem."},{"key":"27318_CR23","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/s41577-020-00429-3","volume":"20","author":"JS Lee","year":"2020","unstructured":"Lee, J. S. & Shin, E. C. The type I interferon response in COVID-19: implications for treatment. Nat. Rev. Immunol. 20, 585\u2013586 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"27318_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17796-z","volume":"11","author":"N Zhu","year":"2020","unstructured":"Zhu, N. et al. Morphogenesis and cytopathic effect of SARS-CoV-2 infection in human airway epithelial cells. Nat. Commun. 11, 3910 (2020).","journal-title":"Nat. Commun."},{"key":"27318_CR25","doi-asserted-by":"publisher","first-page":"e1009292","DOI":"10.1371\/journal.ppat.1009292","volume":"17","author":"JK Fiege","year":"2021","unstructured":"Fiege, J. K. et al. Single cell resolution of SARS-CoV-2 tropism, antiviral responses, and susceptibility to therapies in primary human airway epithelium. PLoS Pathog. 17, e1009292 (2021).","journal-title":"PLoS Pathog."},{"key":"27318_CR26","doi-asserted-by":"publisher","unstructured":"Vanderheiden, A. et al. Type I and Type III Interferons Restrict SARS-CoV-2 Infection of Human Airway Epithelial Cultures. J Virol 94, https:\/\/doi.org\/10.1128\/JVI.00985-20 (2020).","DOI":"10.1128\/JVI.00985-20"},{"key":"27318_CR27","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","volume":"181","author":"D Blanco-Melo","year":"2020","unstructured":"Blanco-Melo, D. et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell 181, 1036\u20131045 e1039 (2020).","journal-title":"Cell"},{"key":"27318_CR28","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.stem.2020.09.013","volume":"27","author":"J Huang","year":"2020","unstructured":"Huang, J. et al. SARS-CoV-2 Infection of pluripotent stem cell-derived human lung alveolar type 2 cells elicits a rapid epithelial-intrinsic inflammatory response. Cell Stem Cell. 27, 962\u2013973.e7 (2020).","journal-title":"Cell Stem Cell"},{"key":"27318_CR29","doi-asserted-by":"publisher","first-page":"L1158","DOI":"10.1152\/ajplung.00414.2019","volume":"318","author":"E Mavin","year":"2020","unstructured":"Mavin, E. et al. Real-time measurement of cellular bioenergetics in fully differentiated human nasal epithelial cells grown at air-liquid-interface. Am. J. Physiol. Lung Cell Mol. Physiol. 318, L1158\u2013L1164 (2020).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"27318_CR30","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1038\/s41591-019-0468-5","volume":"25","author":"FA Vieira Braga","year":"2019","unstructured":"Vieira Braga, F. A. et al. A cellular census of human lungs identifies novel cell states in health and in asthma. Nat. Med 25, 1153\u20131163 (2019).","journal-title":"Nat. Med"},{"key":"27318_CR31","doi-asserted-by":"publisher","unstructured":"Ruiz Garcia, S. et al. Novel dynamics of human mucociliary differentiation revealed by single-cell RNA sequencing of nasal epithelial cultures. Development 146, https:\/\/doi.org\/10.1242\/dev.177428 (2019).","DOI":"10.1242\/dev.177428"},{"key":"27318_CR32","doi-asserted-by":"publisher","first-page":"12256","DOI":"10.1021\/acs.jmedchem.0c00502","volume":"63","author":"S Xiu","year":"2020","unstructured":"Xiu, S. et al. Inhibitors of SARS-CoV-2 entry: current and future opportunities. J. Med. Chem. 63, 12256\u201312274 (2020).","journal-title":"J. Med. Chem."},{"key":"27318_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24817-y","volume":"12","author":"C Prelli Bozzo","year":"2021","unstructured":"Prelli Bozzo, C. et al. IFITM proteins promote SARS-CoV-2 infection and are targets for virus inhibition in vitro. Nat. Commun. 12, 4584 (2021).","journal-title":"Nat. Commun."},{"key":"27318_CR34","doi-asserted-by":"publisher","unstructured":"Li, S. et al. Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2-induced systemic toxicity. JCI Insight 6, https:\/\/doi.org\/10.1172\/jci.insight.145027 (2021).","DOI":"10.1172\/jci.insight.145027"},{"key":"27318_CR35","doi-asserted-by":"publisher","first-page":"105114","DOI":"10.1016\/j.micpath.2021.105114","volume":"158","author":"STR Moolamalla","year":"2021","unstructured":"Moolamalla, S. T. R., Balasubramanian, R., Chauhan, R., Priyakumar, U. D. & Vinod, P. K. Host metabolic reprogramming in response to SARS-CoV-2 infection: a systems biology approach. Micro. Pathog. 158, 105114 (2021).","journal-title":"Micro. Pathog."},{"key":"27318_CR36","doi-asserted-by":"publisher","first-page":"e3001143","DOI":"10.1371\/journal.pbio.3001143","volume":"19","author":"NG Ravindra","year":"2021","unstructured":"Ravindra, N. G. et al. Single-cell longitudinal analysis of SARS-CoV-2 infection in human airway epithelium identifies target cells, alterations in gene expression, and cell state changes. PLoS Biol. 19, e3001143 (2021).","journal-title":"PLoS Biol."},{"key":"27318_CR37","volume":"11","author":"X Lei","year":"2020","unstructured":"Lei, X. et al. Activation and evasion of type I interferon responses by SARS-CoV-2. Nat. Commun. 11, 3810 (2020).","journal-title":"Nat. Commun."},{"key":"27318_CR38","doi-asserted-by":"publisher","unstructured":"Cardoso, R. S. et al. Host retromer protein sorting Nexin 2 interacts with human respiratory syncytial virus structural proteins and is required for efficient viral production. mBio 11, https:\/\/doi.org\/10.1128\/mBio.01869-20 (2020).","DOI":"10.1128\/mBio.01869-20"},{"key":"27318_CR39","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1600-0854.2011.01320.x","volume":"13","author":"M Bergant Marusic","year":"2012","unstructured":"Bergant Marusic, M., Ozbun, M. A., Campos, S. K., Myers, M. P. & Banks, L. Human papillomavirus L2 facilitates viral escape from late endosomes via sorting nexin 17. Traffic 13, 455\u2013467 (2012).","journal-title":"Traffic"},{"key":"27318_CR40","doi-asserted-by":"publisher","unstructured":"Duncan, C. J. A. et al. Severe type I interferonopathy and unrestrained interferon signaling due to a homozygous germline mutation in STAT2. Sci. Immunol. 4, https:\/\/doi.org\/10.1126\/sciimmunol.aav7501 (2019).","DOI":"10.1126\/sciimmunol.aav7501"},{"key":"27318_CR41","doi-asserted-by":"publisher","unstructured":"Monk, P. D. et al. Safety and efficacy of inhaled nebulised interferon beta-1a (SNG001) for treatment of SARS-CoV-2 infection: a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Respir. Med. https:\/\/doi.org\/10.1016\/S2213-2600(20)30511-7 (2020).","DOI":"10.1016\/S2213-2600(20)30511-7"},{"key":"27318_CR42","doi-asserted-by":"publisher","first-page":"104450","DOI":"10.1016\/j.jcv.2020.104450","volume":"128","author":"G Antonelli","year":"2020","unstructured":"Antonelli, G. et al. Type I interferons can be detected in respiratory swabs from SARS-Cov-2 infected patients. J. Clin. Virol. 128, 104450 (2020).","journal-title":"J. Clin. Virol."},{"key":"27318_CR43","doi-asserted-by":"publisher","unstructured":"Cheemarla, N. R. et al. Dynamic innate immune response determines susceptibility to SARS-CoV-2 infection and early replication kinetics. J. Exp. Med. 218, https:\/\/doi.org\/10.1084\/jem.20210583 (2021).","DOI":"10.1084\/jem.20210583"},{"key":"27318_CR44","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19587-y","volume":"11","author":"E Mick","year":"2020","unstructured":"Mick, E. et al. Upper airway gene expression reveals suppressed immune responses to SARS-CoV-2 compared with other respiratory viruses. Nat. Commun. 11, 5854 (2020).","journal-title":"Nat. Commun."},{"key":"27318_CR45","doi-asserted-by":"publisher","unstructured":"Rebendenne, A. et al. SARS-CoV-2 triggers an MDA-5-dependent interferon response which is unable to control replication in lung epithelial cells. J. Virol. https:\/\/doi.org\/10.1128\/JVI.02415-20 (2021).","DOI":"10.1128\/JVI.02415-20"},{"key":"27318_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92940-3","volume":"11","author":"NG Sampaio","year":"2021","unstructured":"Sampaio, N. G. et al. The RNA sensor MDA5 detects SARS-CoV-2 infection. Sci. Rep. 11, 13638 (2021).","journal-title":"Sci. Rep."},{"key":"27318_CR47","doi-asserted-by":"publisher","first-page":"108628","DOI":"10.1016\/j.celrep.2020.108628","volume":"34","author":"X Yin","year":"2021","unstructured":"Yin, X. et al. MDA5 Governs the innate immune response to SARS-CoV-2 in lung epithelial cells. Cell Rep. 34, 108628 (2021).","journal-title":"Cell Rep."},{"key":"27318_CR48","doi-asserted-by":"publisher","first-page":"e0026621","DOI":"10.1128\/JVI.00266-21","volume":"95","author":"A Kumar","year":"2021","unstructured":"Kumar, A. et al. SARS-CoV-2 nonstructural protein 1 inhibits the interferon response by causing depletion of key host signaling factors. J. Virol. 95, e0026621 (2021).","journal-title":"J. Virol."},{"key":"27318_CR49","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1016\/j.tim.2020.05.009","volume":"28","author":"G Wolff","year":"2020","unstructured":"Wolff, G., Melia, C. E., Snijder, E. J. & Barcena, M. Double-membrane vesicles as platforms for viral replication. Trends Microbiol 28, 1022\u20131033 (2020).","journal-title":"Trends Microbiol"},{"key":"27318_CR50","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41586-021-03610-3","volume":"594","author":"Y Finkel","year":"2021","unstructured":"Finkel, Y. et al. SARS-CoV-2 uses a multipronged strategy to impede host protein synthesis. Nature 594, 240\u2013245 (2021).","journal-title":"Nature"},{"key":"27318_CR51","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1038\/s41594-020-0511-8","volume":"27","author":"K Schubert","year":"2020","unstructured":"Schubert, K. et al. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation. Nat. Struct. Mol. Biol. 27, 959\u2013966 (2020).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"27318_CR52","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1126\/science.abc8665","volume":"369","author":"M Thoms","year":"2020","unstructured":"Thoms, M. et al. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2. Science 369, 1249\u20131255 (2020).","journal-title":"Science"},{"key":"27318_CR53","doi-asserted-by":"publisher","unstructured":"Hsu, J. C., Laurent-Rolle, M., Pawlak, J. B., Wilen, C. B. & Cresswell, P. Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein. Proc. Natl Acad. Sci. USA 118, https:\/\/doi.org\/10.1073\/pnas.2101161118 (2021).","DOI":"10.1073\/pnas.2101161118"},{"key":"27318_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24521-x","volume":"12","author":"R Robinot","year":"2021","unstructured":"Robinot, R. et al. SARS-CoV-2 infection induces the dedifferentiation of multiciliated cells and impairs mucociliary clearance. Nat. Commun. 12, 4354 (2021).","journal-title":"Nat. Commun."},{"key":"27318_CR55","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41590-020-00840-x","volume":"22","author":"IE Galani","year":"2021","unstructured":"Galani, I. E. et al. Untuned antiviral immunity in COVID-19 revealed by temporal type I\/III interferon patterns and flu comparison. Nat. Immunol. 22, 32\u201340 (2021).","journal-title":"Nat. Immunol."},{"key":"27318_CR56","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1126\/science.abc6027","volume":"369","author":"J Hadjadj","year":"2020","unstructured":"Hadjadj, J. et al. Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients. Science 369, 718\u2013724 (2020).","journal-title":"Science"},{"key":"27318_CR57","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1038\/s41591-021-01329-2","volume":"27","author":"E Stephenson","year":"2021","unstructured":"Stephenson, E. et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat. Med. 27, 904\u2013916 (2021).","journal-title":"Nat. Med."},{"key":"27318_CR58","doi-asserted-by":"publisher","unstructured":"Lopez, J. et al. Early nasal type I IFN immunity against SARS-CoV-2 is compromised in patients with autoantibodies against type I IFNs. J. Exp. Med. 218, https:\/\/doi.org\/10.1084\/jem.20211211 (2021).","DOI":"10.1084\/jem.20211211"},{"key":"27318_CR59","doi-asserted-by":"publisher","unstructured":"Molony, R. D. et al. Aging impairs both primary and secondary RIG-I signaling for interferon induction in human monocytes. Sci. Signal 10, https:\/\/doi.org\/10.1126\/scisignal.aan2392 (2017).","DOI":"10.1126\/scisignal.aan2392"},{"key":"27318_CR60","doi-asserted-by":"publisher","unstructured":"Loske, J. et al. Pre-activated antiviral innate immunity in the upper airways controls early SARS-CoV-2 infection in children. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-021-01037-9 (2021).","DOI":"10.1038\/s41587-021-01037-9"},{"key":"27318_CR61","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.stem.2020.11.010","volume":"27","author":"A Purkayastha","year":"2020","unstructured":"Purkayastha, A. et al. Direct exposure to SARS-CoV-2 and cigarette smoke increases infection severity and alters the stem cell-derived airway repair response. Cell Stem Cell 27, 869\u2013875 e864 (2020).","journal-title":"Cell Stem Cell"},{"key":"27318_CR62","doi-asserted-by":"publisher","first-page":"1278","DOI":"10.1128\/CVI.00172-06","volume":"13","author":"E Hartmann","year":"2006","unstructured":"Hartmann, E. et al. Analysis of plasmacytoid and myeloid dendritic cells in nasal epithelium. Clin. Vaccin. Immunol. 13, 1278\u20131286 (2006).","journal-title":"Clin. Vaccin. Immunol."},{"key":"27318_CR63","doi-asserted-by":"publisher","unstructured":"Onodi, F. et al. SARS-CoV-2 induces human plasmacytoid pre-dendritic cell diversification via UNC93B and IRAK4. bioRxiv. Preprint at https:\/\/doi.org\/10.1101\/2020.07.10.197343 (2021).","DOI":"10.1101\/2020.07.10.197343"},{"key":"27318_CR64","doi-asserted-by":"publisher","unstructured":"Cervantes-Barragan, L. et al. Plasmacytoid dendritic cells produce type I interferon and reduce viral replication in airway epithelial cells after SARS-CoV-2 infection. bioRxiv. Preprint at https:\/\/doi.org\/10.1101\/2021.05.12.443948 (2021).","DOI":"10.1101\/2021.05.12.443948"},{"key":"27318_CR65","doi-asserted-by":"publisher","unstructured":"Pierce, C. A. et al. Natural mucosal barriers and COVID-19 in children. JCI Insight 6, https:\/\/doi.org\/10.1172\/jci.insight.148694 (2021).","DOI":"10.1172\/jci.insight.148694"},{"key":"27318_CR66","doi-asserted-by":"publisher","first-page":"4713","DOI":"10.1016\/j.cell.2021.07.023","volume":"184","author":"CGK Ziegler","year":"2021","unstructured":"Ziegler, C. G. K. et al. Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19. Cell. 184, 4713\u20134733 (2021).","journal-title":"Cell"},{"key":"27318_CR67","doi-asserted-by":"publisher","first-page":"12771","DOI":"10.1073\/pnas.0906850106","volume":"106","author":"JR Rock","year":"2009","unstructured":"Rock, J. R. et al. Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc. Natl Acad. Sci. USA 106, 12771\u201312775 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"27318_CR68","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41577-020-00477-9","volume":"21","author":"RJ Hewitt","year":"2021","unstructured":"Hewitt, R. J. & Lloyd, C. M. Regulation of immune responses by the airway epithelial cell landscape. Nat. Rev. Immunol. 21, 347\u2013362 (2021).","journal-title":"Nat. Rev. Immunol."},{"key":"27318_CR69","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1084\/jem.20171978","volume":"216","author":"N Fujino","year":"2019","unstructured":"Fujino, N. et al. Sensing of apoptotic cells through Axl causes lung basal cell proliferation in inflammatory diseases. J. Exp. Med 216, 2184\u20132201 (2019).","journal-title":"J. Exp. Med"},{"key":"27318_CR70","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/s41586-018-0449-8","volume":"560","author":"J Ordovas-Montanes","year":"2018","unstructured":"Ordovas-Montanes, J. et al. Allergic inflammatory memory in human respiratory epithelial progenitor cells. Nature 560, 649\u2013654 (2018).","journal-title":"Nature"},{"key":"27318_CR71","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.cell.2017.11.018","volume":"172","author":"X Wu","year":"2018","unstructured":"Wu, X. et al. Intrinsic immunity shapes viral resistance of stem cells. Cell 172, 423\u2013438.e425 (2018).","journal-title":"Cell"},{"key":"27318_CR72","doi-asserted-by":"publisher","first-page":"920","DOI":"10.2174\/1568026621666210429083050","volume":"21","author":"Z Meng","year":"2021","unstructured":"Meng, Z. et al. The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area. Curr. Top. Med. Chem. 21, 920\u2013927 (2021).","journal-title":"Curr. Top. Med. Chem"},{"key":"27318_CR73","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19684-y","volume":"11","author":"R Boudewijns","year":"2020","unstructured":"Boudewijns, R. et al. STAT2 signaling restricts viral dissemination but drives severe pneumonia in SARS-CoV-2 infected hamsters. Nat. Commun. 11, 5838 (2020).","journal-title":"Nat. Commun."},{"key":"27318_CR74","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1126\/science.abc2061","volume":"369","author":"J Major","year":"2020","unstructured":"Major, J. et al. Type I and III interferons disrupt lung epithelial repair during recovery from viral infection. Science 369, 712\u2013717 (2020).","journal-title":"Science"},{"key":"27318_CR75","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1126\/science.abc3545","volume":"369","author":"A Broggi","year":"2020","unstructured":"Broggi, A. et al. Type III interferons disrupt the lung epithelial barrier upon viral recognition. Science 369, 706\u2013712 (2020).","journal-title":"Science"},{"key":"27318_CR76","doi-asserted-by":"publisher","unstructured":"Fleming, S. J., Marioni, J. C. & Babadi, M. CellBender remove-background: a deep generative model for unsupervised removal of background noise from scRNA-seq datasets. bioRxiv. Preprint at https:\/\/doi.org\/10.1101\/791699 (2019).","DOI":"10.1101\/791699"},{"key":"27318_CR77","doi-asserted-by":"publisher","unstructured":"Korotkevich, G. et al. Fast gene set enrichment analysis. bioRxiv. Preprint at https:\/\/doi.org\/10.1101\/060012 (2021).","DOI":"10.1101\/060012"},{"key":"27318_CR78","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-020-1949-z","volume":"21","author":"CH Holland","year":"2020","unstructured":"Holland, C. H. et al. Robustness and applicability of transcription factor and pathway analysis tools on single-cell RNA-seq data. Genome Biol. 21, 36 (2020).","journal-title":"Genome Biol."},{"key":"27318_CR79","unstructured":"Hatton, C. F. et al. (Github, 2021) https:\/\/github.com\/haniffalab\/covid_nasal_epithelium."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27318-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27318-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27318-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T14:13:07Z","timestamp":1669990387000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-27318-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,7]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["27318"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-27318-0","relation":{"has-review":[{"id-type":"doi","id":"10.32388\/AX0WGG","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.02.17.431591","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,7]]},"assertion":[{"value":"16 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 December 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"S.H. declares honoraria from CSL Behring and Takeda for teaching and consultancy. M.B. declares being\u00a0CI on investigator-led research grants from Pfizer and Roche Diagnostics; speaker fees paid to Newcastle University from Novartis, Roche Diagnostics and TEVA; travel expenses to educational meetings from Boehringer Ingelheim and Vertex.\u00a0The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7092"}}